FDA clears neuroimaging software from Advantis

By AuntMinnie.com staff writers

November 16, 2021 -- The U.S. Food and Drug Administration (FDA) has cleared Advantis Medical Imaging's Brainance MD neuroimaging software platform for analyzing brain MRI exams.

Brainance MD displays, processes, and analyses diffusion tensor imaging, dynamic susceptibility contrast perfusion, and functional MRI brain images. The company is offering it as software-as-service, it said.

The software has the CE Mark and is already being used in Europe, according to Advantis.


Copyright © 2021 AuntMinnie.com
 

To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking
account: